Table 1. Patient and treatment characteristics for thymoma patients (N=6).
| Characteristic | Value |
|---|---|
| Sex | |
| Male | 2 |
| Female | 4 |
| Median age [range], years | 59.5 [23–74] |
| Masaoka stage, n [%] | |
| I | 0 |
| II | 2 [33] |
| III | 4 [67] |
| IV | 0 |
| Radiotherapy approach, n [%] | |
| Definitive proton therapy | 1 [17] |
| Postoperative proton therapy | 5 [83] |
| Median radiotherapy dose, Gy | 60 (RBE) (range, 54–70) |
| Surgical margins for post-op patients, n [%] | |
| Negative (R0 resection) | 0 |
| Positive (R1 or R2 resection) | 5 [83] |
| Adjuvant chemotherapy, n [%] | 2 [33] |
RBE, relative biological effectiveness.